Although this study has presented some insight into the dynamics of adiponectin in SCA clearly, it is limited because a larger longitudinal study starting from when the patients are in steady state through crisis state would have given further insight into the dynamics of adiponectin and BMI in these patients, thereby making for a better patient treatment, monitoring, and outcome. This evidence concerns the gene ADIPOQ and autosomal dominant cerebellar ataxia.